Heather Clouting, M.Sc.
Director of CMC and Project Management
Heather Clouting MSc. earned a bachelor’s degree with honors in chemistry in 2002 from Kingston University, London, United Kingdom, and master’s degree in clinical trials in 2009 from The London School of Hygiene and Tropical Medicine, London. Prior to joining the MAPS Public Benefit Corporation (MPBC), Heather has worked in the field of clinical research for nearly 15 years. This included 5 years at the Medical Research Council Clinical Trials Unit in London as a Data Manager and Clinical Trial Manager working mainly on HIV and tuberculosis studies in sub-Saharan Africa and 6+ years in the pharmaceutical industry working for Novartis Vaccines and GSK in a variety of roles including Clinical Research Scientist, Senior Clinical Trial Leader, Clinical Operations Manager and Project Delivery Lead. In the last few years she has worked as an independent consultant for small biotech and nonprofit pharmaceutical organizations including MAPS/MPBC in the capacity of program project management, regulatory strategy and chemistry manufacturing and controls (CMC).
At MPBC, Heather is currently serving as the Director of CMC and Project Management working on clinical and commercial CMC, IMP supplies and logistics, nonclinical toxicology program project management, and other cross functional project management activities to support the MPBC programs and eventual NDA submission of MDMA-assisted psychotherapy for PTSD.
Heather is passionate about the potential expansion of the appropriate use of psychedelics and related healthcare modalities to support metal health indications. She believes that a for-profit model of health care provision and drug development, although in some cases needed, in others can have intrinsic conflict of interest and as a result is excited to be part of an organization that
is developing potential new treatments for mental health disorders that utilize a public benefit approach.